ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

BEAM Beam Therapeutics Inc

21.74
0.00 (0.00%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Beam Therapeutics Inc BEAM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 21.74 09:00:00
始値 安値 高値 終値 前日終値
21.74
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2619:30GLOBEBeam Therapeutics Announces Clearance of Clinical Trial..
2024/2/2820:30GLOBEBeam Therapeutics to Participate in Upcoming March 2024..
2024/2/2721:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2721:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2720:43EDGAR2Form 8-K - Current report
2024/2/2720:30GLOBEBeam Therapeutics Reports Fourth Quarter and Year-End 2023..
2024/2/0520:30GLOBEBeam Therapeutics to Participate in the Guggenheim..
2024/2/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:47EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0820:55EDGAR2Form 8-K - Current report
2024/1/0820:30GLOBEBeam Therapeutics Highlights Progress Across Base Editing..
2024/1/0606:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0220:30GLOBEBeam Therapeutics to Present at the 42nd Annual J.P. Morgan..
2023/12/1506:05EDGAR2Form 8-K - Current report
2023/12/1420:30GLOBEBeam Therapeutics Appoints Biotech Executive Christi Shaw to..
2023/11/2106:20EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0821:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:00EDGAR2Form 8-K - Current report
2023/11/0820:30GLOBEBeam Therapeutics Reports Pipeline and Business Updates and..
2023/11/0205:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3119:59DJNBeam Therapeutics to Sell Rights in Verve Licensing Deal to..
2023/10/3119:44EDGAR2Form 8-K - Current report
2023/10/3119:00GLOBEBeam Announces Agreement for Lilly to Acquire Beam’s Opt-In..
2023/10/3105:41EDGAR2Form 144 - Report of proposed sale of securities
2023/10/2519:30GLOBEBeam Therapeutics Presents Preclinical Data Highlighting..
2023/10/2505:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1921:50EDGAR2Form 8-K - Current report
2023/10/1921:45GLOBEBeam Therapeutics Announces Portfolio Prioritization and..
2023/10/0505:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0723:00GLOBEBeam Therapeutics Presents Preclinical Data Highlighting..
2023/9/0519:30GLOBEBeam Therapeutics Announces First Patient Dosed in Phase 1/2..
2023/8/3119:30GLOBEBeam Therapeutics to Participate in Upcoming September..
2023/8/1005:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0820:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:11EDGAR2Form 8-K - Current report
2023/8/0819:30GLOBEBeam Therapeutics Reports Pipeline Updates and Second..
2023/7/2607:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2207:31EDGAR2Form 144 - Report of proposed sale of securities
2023/5/1719:30GLOBEBeam Therapeutics to Participate in Upcoming May Investor..
2023/5/1119:30GLOBEBeam Therapeutics to Participate in RBC Capital Markets 2023..
2023/5/1019:30GLOBEBeam Therapeutics Reports Pipeline Updates and First Quarter..

最近閲覧した銘柄

Delayed Upgrade Clock